Your browser doesn't support javascript.
loading
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment.
Zhang, Na; Liu, Xiaohong; Qin, Juliang; Sun, Yue; Xiong, Hao; Lin, Boxu; Liu, Kexin; Tan, Binghe; Zhang, Chenglin; Huang, Chenshen; Ren, Shancheng; Liu, Mingyao; Du, Bing.
  • Zhang N; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China; BRL Medicine, Inc, Shanghai 201109, China.
  • Liu X; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Qin J; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Sun Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Xiong H; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Lin B; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Liu K; BRL Medicine, Inc, Shanghai 201109, China.
  • Tan B; BRL Medicine, Inc, Shanghai 201109, China.
  • Zhang C; Department of Orthopedics, Shanghai Changzheng Hospital, Shanghai 200003, China.
  • Huang C; Department of Gastrointestinal Surgery, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.
  • Ren S; Department of Urology, Shanghai Changzheng Hospital, Shanghai 200003, China. Electronic address: renshancheng@gmail.com.
  • Liu M; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China. Electronic address: myliu@bio.ecnu.edu.cn.
  • Du B; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China. Electronic address: bdu@bio.ecnu.edu.cn.
Mol Ther ; 31(9): 2575-2590, 2023 09 06.
Article en En | MEDLINE | ID: mdl-37408308
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miembro 14 de la Superfamilia de Ligandos de Factores de Necrosis Tumoral / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miembro 14 de la Superfamilia de Ligandos de Factores de Necrosis Tumoral / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article